Johnson & Johnson
NYSE: JNJ
$154.65
+$0.65 (+0.4%)
Real Time Data Delayed 15 Min.
JNJ Articles
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
Published:
Last Updated:
Friday's top analyst upgrades, downgrades and initiations included Apple, Canopy Growth, CrowdStrike, Delta Air Lines, Johnson & Johnson, Rio Tinto, Roku, Square, Tilray and Twilio.
Published:
Last Updated:
Johnson & Johnson shares dropped on Wednesday following the announcement that a jury has awarded $8 billion in damages to a man accusing the drugmaker of failing to warn about the side effects of...
Published:
Last Updated:
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
Published:
Last Updated:
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the...
Published:
Last Updated:
The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid long-term prospects.
Published:
Last Updated:
As, when and if ESG themes continue to gain in popularity, imagine what could happen to some of the top-ranked ESG companies. Imagine also what could happen to some of the companies that are...
Published:
Last Updated:
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
Published:
Last Updated:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to blame. Some rivals may have been winning at the company's expense.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray and VMware.
Published:
Last Updated:
Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings that shareholders are having a hard time quantifying.
Published:
Last Updated:
Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Published:
Last Updated:
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Johnson & Johnson, Microsoft, Netflix and the other most prominent of the many earnings reports that are expected this week.
Published:
Last Updated: